Title
Definition
Pathogenesis
Bronchiectasis can result from lesions in the following:
Lumen
Obstruction by:
Ñ
Mucous plug
Ñ
Tumour
Ñ
Inhaled foreign body
Mural Factors
Infections
Especially childhood infections:
Ñ
Measles, whooping cough
Other infections:
Ñ
Tuberculosis, pneumococcal pneumonia, adenovirus and AIDS
Mucociliary Clearance Defects
Ñ
Cystic fibrosis
Ñ
Immotile cilia
Ñ
Kartagener’s syndrome
Miscellaneous
Ñ
Marfan’s syndrome
Ñ
Yellow nail syndrome
External Factors
Ñ
Fibrosis of the lungs
Ñ
Compression by a lymph node
Systemic Factors
HS
Immune deficiency states:
Ñ
Hypogammaglobulinaemia
Ñ
Complement deficiency
Ñ
Phagocyte defects
Ñ
Chronic granulomatous disease
RS
Hyperimmune states:
Ñ
Allergic bronchopulmonary aspergillosis
Ñ
Following lung transplantation
GIT
Ñ
Inflammatory bowel disease
Ñ
Gastric aspiration
LMS
Ñ
Rheumatoid arthritis
Pathological Process
Ñ
Damage to the bronchial wall occurs in the setting of:
An infectious insult
Impairment of drainage
Airway obstruction
Defect in host defence
Ñ
Neutrophil proteases, inflammatory cytokines, nitric oxide,
oxygen free radicals cause tissue damage
Ñ
Muscular and elastic components of the bronchial wall are
damaged
Ñ
In addition, peribronchial alveolar tissue may be damaged,
resulting in diffuse peribronchial fibrosis
Ñ
The result is abnormal bronchial dilatation with bronchial wall
destruction and transmural inflammation.
Ñ
Functionally, this severely impairs clearance of secretions from
the bronchial tree
Ñ
Impaired clearance of secretions causes colonisation and
infection with pathogenic organisms
Ñ
This results in further bronchial damage and a cycle of
bronchial damage, bronchial dilation, impaired clearance of secretions,
recurrent infection and more bronchial damage
Clinical Features
History
E&M
RS
Examination
E&M
IS
RS
Complications
IS
CVS
RS
KUS
LMS
Investigations
Fluids
Sputum
Major pathogens include:
Ñ
Staphylococcus aureus
Ñ
Pseudomonas
aeroginosa
Ñ
Haemophilus
influenzae
Ñ
Anaerobes
Blood
Immunology
Imaging
Physiological studies
Management
Control
Drugs
Surgery
Staffing
Prognosis